telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg	valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg	mean reduction in BP for both systolic blood pressure (SBP) and diastolic blood pressure (DBP) 	8836	9130	Treatment with T80/H25 was associated with a significantly greater mean reduction in BP compared with V160/H25 for both SBP (adjusted mean difference −2.7 mm Hg; 95% confidence interval (CI), −5.1, −0.3; P = 0.0265) and DBP (adjusted mean difference −2.0 mm Hg; 95% CI, −3.4, −0.6; P = 0.0041).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg	valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg	reduction in BP for systolic blood pressure (SBP) and diastolic blood pressure (DBP) 	9659	9898	T80/H25 resulted in significantly greater BP reductions from baseline (adjusted mean SBP/DBP change −31.6/−18.0 mm Hg) than V160/H25 (adjusted mean SBP/DBP change −28.0/−15.8 mm Hg; P = 0.0063 for difference in SBP and P = 0.0041 for DBP).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg	valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg	DBP change among non-Black patients	10866	11067	Among non-Black patients, T80/H25 resulted in significantly greater DBP reductions from baseline (adjusted mean DBP change −18.3 mm Hg) than V160/H25 (adjusted mean DBP change −16.5 mm Hg; P = 0.0229).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg	valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg	mean reduction in BP for both systolic blood pressure (SBP) and diastolic blood pressure (DBP) 	939	1119	Treatment with telmisartan-HCTZ induced significantly greater reductions in BP (−31.1/−18.3 mm Hg) than valsartan-HCTZ (−28.4/−16.3 mm Hg; SBP P = 0.0265, diastolic BP P = 0.0041).
telmisartan 80 mg combined with hydrochlorothiazide (HCTZ) 25 mg	valsartan 160 mg combined with hydrochlorothiazide (HCTZ) 25 mg	reduction in BP for systolic blood pressure (SBP) and diastolic blood pressure (DBP) 	9631	9898	In patients aged <65 years, T80/H25 resulted in significantly greater BP reductions from baseline (adjusted mean SBP/DBP change −31.6/−18.0 mm Hg) than V160/H25 (adjusted mean SBP/DBP change −28.0/−15.8 mm Hg; P = 0.0063 for difference in SBP and P = 0.0041 for DBP).
